Categories: Health

Pfizer can’t sell vaccine in India as it is not ready to go for local trials

<p>
US pharma major Pfizer Inc said on Friday it had withdrawn its application for emergency-use authorisation of its COVID-19 vaccine in India, after failing to comply with the drug regulator’s rules for carrying out a local safety and immunogenicity trial for the shots.</p>
<p>
The decision means the vaccine will not be available for sale in India in the near future.</p>
<p>
Unlike other companies such as Russia's Spuntik V who are carrying out trials in India for vaccines developed abroad, Pfizer had sought an exemption based on trials done in the United States and Germany.</p>
<p>
However, Indian rules stipulate domestic trials as well to determine if a vaccine is safe and generates an immune response in local citizens. There are, however, provisions under India’s rules to waive such trials in certain conditions.</p>
<p>
Central Drugs Standard Control Organisation said its experts did not recommend the vaccine because side effects reported abroad were still being investigated. It also said Pfizer had not proposed any plan to generate safety and immunogenicity data in India.</p>
<p>
Pfizer said, “Based on the deliberations at the meeting and our understanding of additional information that the regulator may need, the company has decided to withdraw its application at this time.”</p>
<p>
“Pfizer will continue to engage with the authority and re-submit its approval request with additional information as it becomes available in the near future,” the company said.</p>
<p>
Pfizer had sought authorisation for its vaccine in India late last year, but the government in January approved two much cheaper vaccines which are being produced in India. While one is being manufactured by Pune-based Serum Institute in collaboration with UK pharma giant AstraZeneca and Oxford University, the second has been developed in India by Bharat Biotech with the Indian Council of Medical Research. Both vaccines have been cleared for emergency use.</p>
<p>
Local company Dr. Reddy’s Laboratories Ltd is running trials for Russia’s Sputnik V vaccine, which is expected to be approved in the coming weeks. The vaccine has already been cleared for mass use in Russia.</p>

IN Bureau

Recent Posts

“Yoga India’s gift to world, Int’l Yoga Day should be celebrated by all”: Envoys on International Day of Yoga

Australia's High Commissioner to India, Philip Green OAM, called Yoga one of India's gifts to…

12 hours ago

BSNL soft launches Quantum 5G FWA

The Bharat Sanchar Nigam Limited (BSNL) has announced the soft launch of BSNL Quantum 5G…

14 hours ago

India to evacuate citizens of Nepal, Sri Lanka from Iran

The Indian Embassy in Iran has said that the embassy will make efforts to evacuate…

14 hours ago

Direct tax collections rise 4.86% in FY26 so far, net collections dip on higher refunds

India's gross direct tax collections for the financial year 2025-26 rose by 4.86 per cent…

15 hours ago

“Not seeking the surrender of Ukraine, insist on recognition of realities”: Putin at International Economic Forum

Russian President Vladimir Putin has said that Moscow is not seeking Ukraine's unconditional surrender, but…

15 hours ago

World has recognised yoga’s scientific importance: LS Speaker Om Birla

Extending his greetings on the 11th International Day of Yoga, Lok Sabha speaker Om Birla…

15 hours ago